Standard Chemical & Pharmaceutical Co. Ltd. (TPE: 1720)
Taiwan
· Delayed Price · Currency is TWD
60.90
0.00 (0.00%)
Jan 20, 2025, 1:30 PM CST
Standard Chemical & Pharmaceutical Revenue
Standard Chemical & Pharmaceutical had revenue of 1.74B TWD in the quarter ending September 30, 2024, with 5.89% growth. This brings the company's revenue in the last twelve months to 6.71B, up 7.66% year-over-year. In the year 2023, Standard Chemical & Pharmaceutical had annual revenue of 6.24B with 6.64% growth.
Revenue (ttm)
6.71B
Revenue Growth
+7.66%
P/S Ratio
1.62
Revenue / Employee
n/a
Employees
n/a
Market Cap
10.88B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 6.24B | 388.40M | 6.64% |
Dec 31, 2022 | 5.85B | 1.25B | 27.09% |
Dec 31, 2021 | 4.60B | 298.68M | 6.94% |
Dec 31, 2020 | 4.31B | 368.27M | 9.35% |
Dec 31, 2019 | 3.94B | 364.04M | 10.19% |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Dec 31, 2014 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
PharmaEssentia | 8.32B |
Caliway Biopharmaceuticals | 49.98M |
Bora Pharmaceuticals Co., LTD. | 16.71B |
Lotus Pharmaceutical | 17.59B |
Lumosa Therapeutics | 37.82M |
Oneness Biotech | 112.20M |
Polaris Group | 75.65M |
Center Laboratories | 1.57B |